Jessica Chubak
Biographic Data
| ID | 5540153 |
|---|---|
| NAME | Jessica Chubak |
| GIVEN NAMES | Jessica |
| FAMILY NAME | Chubak |
| SIGNATURE | CHUBAK J |
| AFFILIATIONS | Kaiser Permanente Washington Health Research Institute |
| ORCID | 0000-0003-1630-9021 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
An Electronic Health Record–based Algorithm to Ascertain the Date of Second Breast Cancer Events
OBJECTIVES: Studies of cancer recurrences and second primary tumors require information on outcome dates. Little is known about how well electronic health record-based algorithms can identify dates or how errors in dates can bias analyses. RESEARCH DESIGN: We assessed rule-based and model-fitting approaches to assign event dates using a previously published electronic health record-based algorithm for second breast cancer events (SBCE). We conduc…
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% report…
What can epidemiology contribute to comparative effectiveness research
For many of us, the answer is yes. Comparative effectiveness may have been formally defined only recently as ‘the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care’1 but it is not entirely new. Authors publishing in the Journal of Epidemiology and Community Health used the term at least as far back as 198…
Design of a Randomized Controlled Trial of a Web-Based Intervention to Reduce Cardiovascular Disease Risk Factors Among Remote Reservation–Dwelling American Indian Adults with Type 2 Diabetes
Cost of Breast-Related Care in the Year Following False Positive Screening Mammograms
OBJECTIVE: We sought to estimate the direct cost, from the perspective of the health insurer or purchaser, of breast-care services in the year following a false positive screening mammogram compared with a true negative examination. DESIGN: We identified 21,125 women aged 40 to 80 years enrolled in an integrated healthcare delivery system in Washington State, who participated in screening mammography between January 1, 1998 and July 30, 2002. Pat…
No prominent works on this page.
Cost of Breast-Related Care in the Year Following False Positive Screening Mammograms
OBJECTIVE: We sought to estimate the direct cost, from the perspective of the health insurer or purchaser, of breast-care services in the year following a false positive screening mammogram compared with a true negative examination. DESIGN: We identified 21,125 women aged 40 to 80 years enrolled in an integrated healthcare delivery system in Washington State, who participated in screening mammography between January 1, 1998 and July 30, 2002. Pat…
Design of a Randomized Controlled Trial of a Web-Based Intervention to Reduce Cardiovascular Disease Risk Factors Among Remote Reservation–Dwelling American Indian Adults with Type 2 Diabetes
What can epidemiology contribute to comparative effectiveness research
For many of us, the answer is yes. Comparative effectiveness may have been formally defined only recently as ‘the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care’1 but it is not entirely new. Authors publishing in the Journal of Epidemiology and Community Health used the term at least as far back as 198…
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% report…
An Electronic Health Record–based Algorithm to Ascertain the Date of Second Breast Cancer Events
OBJECTIVES: Studies of cancer recurrences and second primary tumors require information on outcome dates. Little is known about how well electronic health record-based algorithms can identify dates or how errors in dates can bias analyses. RESEARCH DESIGN: We assessed rule-based and model-fitting approaches to assign event dates using a previously published electronic health record-based algorithm for second breast cancer events (SBCE). We conduc…
Medicine (5 works) · Internal Medicine (4 works) · Breast cancer (3 works) · Cancer (3 works) · Health care (3 works) · Confidence interval (2 works) · Family medicine (2 works) · Gerontology (2 works) · Global Cancer Incidence and Screening (2 works) · Gynecology (2 works)